Overview of the main outcomes in breast-cancer prevention trials.
about
GPER Function in Breast Cancer: An OverviewFruit and vegetables and cancer riskTamoxifen induces expression of immune response-related genes in cultured normal human mammary epithelial cellsTamoxifen: catalyst for the change to targeted therapyThe changing global patterns of female breast cancer incidence and mortalityOestrogen exposure and breast cancer riskAssessing subgroup effects with binary data: can the use of different effect measures lead to different conclusions?New concepts and challenges in the clinical translation of cancer preventive therapies: the role of pharmacodynamic biomarkersMetabolism and breast cancer risk: frontiers in research and practiceExemestane for breast cancer prevention: a critical shift?Concordance between decision analysis and matching systematic review of randomized controlled trials in assessment of treatment comparisons: a systematic review.Breast cancer chemoprevention: progress and controversy.Breast cancer chemoprevention: old and new approachesTamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomyPrevention of breast cancer in postmenopausal women: approaches to estimating and reducing riskUsing functional data analysis models to estimate future time trends in age-specific breast cancer mortality for the United States and England-WalesThe prescription pattern of Chinese herbal products that contain dang-qui and risk of endometrial cancer among tamoxifen-treated female breast cancer survivors in Taiwan: a population-based studyEndometrial cancer gene panels: clinical diagnostic vs research germline DNA testing.Effects of the conjugated equine estrogen/bazedoxifene tissue-selective estrogen complex (TSEC) on mammary gland and breast cancer in miceSelective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data.Adjuvant Endocrine Therapy in Patients with Ductal Carcinoma In Situ: A Population-Based Retrospective Analysis from 2005 to 2012 in the National Cancer Data BaseOther Gynecologic Cancers: endometrial, ovarian, vulvar and vaginal cancers.Coordinated prophylactic surgical management for women with hereditary breast-ovarian cancer syndrome.Identification of functional networks of estrogen- and c-Myc-responsive genes and their relationship to response to tamoxifen therapy in breast cancer.Tamoxifen-associated Budd-Chiari syndrome complicated by heparin-induced thrombocytopenia and thrombosis: a case report and literature reviewBreast pain.ER-alpha36, a variant of ER-alpha, promotes tamoxifen agonist action in endometrial cancer cells via the MAPK/ERK and PI3K/Akt pathways.Current strategies for the prevention of breast cancerEndometrial profile of tamoxifen and low-dose estradiol combination therapy.Raloxifene inhibits tumor growth and lymph node metastasis in a xenograft model of metastatic mammary cancer.Oral low dose and topical tamoxifen for breast cancer prevention: modern approaches for an old drug.A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancerHow do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention?Prevention of ER-negative breast cancerPrediction of outcome after diagnosis of metachronous contralateral breast cancer.Difluoromethylornithine: the proof is in the polyamines.The PARP inhibitors, veliparib and olaparib, are effective chemopreventive agents for delaying mammary tumor development in BRCA1-deficient miceA randomized phase II presurgical trial of transdermal 4-hydroxytamoxifen gel versus oral tamoxifen in women with ductal carcinoma in situ of the breast.Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630.Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancer
P2860
Q21131274-74C9D233-C530-49E1-A9A9-D58B8DD0D4CAQ22251000-D88CC3EE-9C80-40FC-A521-7F9BF9577339Q23916703-132C35D0-974D-4843-BF0F-D607F97BA333Q24652988-9A7F3BED-11AF-4C96-9209-DFD1B6289E87Q24795947-1ED64EFD-185F-46D1-AFFE-1BE2522C84A7Q24803498-3817B573-B0FB-4A40-B008-81461FD17462Q24806167-2CC74B10-0884-4C13-956F-81137076B963Q26774577-EB3DC649-628A-48AE-9A54-EB810FF450EFQ26823745-A87A7B77-7904-4F49-9116-0AF3B5AE83CDQ27028211-B81ABE62-716F-4F04-A942-C9ABD009E3F3Q27690842-3D684CB9-0092-4926-B8D1-9B6876A1C5C0Q27692587-E2AF0317-8249-4C7B-983A-610B0472C260Q27693259-381B2E63-7E2B-4271-B9D7-C6A52286D3E7Q28300092-9E831984-4F56-4BDE-896C-B3C2CF0EECF9Q28390064-241F38DC-7559-4D6F-92A9-A863B1F0F65DQ28394774-5774C4B7-1182-4B8F-9CF9-1DBBF86AEE5BQ28542574-2B59C1EC-7A55-4A53-A4A3-2DFB394BDE2DQ30234614-0A9F03D2-B9AB-42ED-89B5-8DF9A6489742Q30353161-BD83F9CD-A4E7-4B9C-8658-3B683BBD3910Q30620889-26A37B03-5E53-4F28-8677-961141CF75B7Q30982140-69A8E35F-E797-4AEE-95FB-04DB7C9C5834Q33206391-CD3D95B2-9E01-4826-B1E9-55FBCED53E49Q33328135-4355CE7A-0534-4108-A936-1B3809011155Q33361574-1B75C280-0821-41C3-A112-2EA598BF367DQ33404691-4349A01C-6A00-4F82-85E4-118A0E7F6C8BQ33448094-B343BB46-7498-4483-A3E2-A2B208BDFB47Q33528959-341E62C8-CD90-477B-A367-D1CFACD13645Q33599463-3710F682-4C3D-4539-8E32-7CFA10FC1E37Q33638802-E3D86877-B941-4106-8EA6-E6AA94B89B36Q33722685-28491A8A-A94E-48AF-B8D1-14C233DF7B14Q33739214-1EDF66CB-4A4E-4717-8FDE-26AA16AE8DF8Q33739494-0B5B66B1-48A0-4CA2-9FA5-3C9DDCCDC0E0Q33767120-8257B7CF-FD10-4A83-9F5E-FC51114B1FC0Q33796968-DF9E4493-AA23-4314-AC64-186CFC4C2E18Q33857741-1873AFB1-5FCE-4913-B7F2-480C36A77264Q33859016-CBDB6347-5907-426C-9113-6D79600A7CACQ33874466-B9684FFC-2CC8-4118-AC47-C5FEF27D29D8Q33914381-EF494003-1B0D-45A1-9AE5-AAFC9AFE454FQ33915034-A6AD51F9-15F2-48B9-8E48-4DF59F583C83Q33965106-EBE65C8B-43EF-4887-A0AD-4EDA45FA5567
P2860
Overview of the main outcomes in breast-cancer prevention trials.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Overview of the main outcomes in breast-cancer prevention trials.
@ast
Overview of the main outcomes in breast-cancer prevention trials.
@en
type
label
Overview of the main outcomes in breast-cancer prevention trials.
@ast
Overview of the main outcomes in breast-cancer prevention trials.
@en
prefLabel
Overview of the main outcomes in breast-cancer prevention trials.
@ast
Overview of the main outcomes in breast-cancer prevention trials.
@en
P2093
P1433
P1476
Overview of the main outcomes in breast-cancer prevention trials.
@en
P2093
P304
P356
10.1016/S0140-6736(03)12342-2
P407
P50
P577
2003-01-01T00:00:00Z